FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology and can be used for prevention of tumour development. Method includes introduction of influenza vaccine "Grippol", which is preventively introduced subcutaneously in effective amount.
EFFECT: application of invention makes it possible to increase resistance of organism to tumour development due to anti-tumour action of vaccine.
3 tbl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR INCREASING ANTITUMOUR RESISTANCE, ANTIOXIDANT AND IMMUNOSTIMULATING EFFECTS ON THE BODY | 2019 |
|
RU2755638C2 |
| METHOD FOR INDUCTION OF AN ABSCOPAL ANTITUMOR EFFECT IN THE EXPERIMENTAL MODEL OF EHRLICH'S CARCINOMA | 2020 |
|
RU2736120C2 |
| DRUG FOR INCREASING CANCER RESISTANCE | 2008 |
|
RU2414238C2 |
| METHOD FOR CARRYING OUT PHOTODYNAMIC THERAPY OF SOLID EHRLICH CARCINOMA IN MICE | 2021 |
|
RU2774589C1 |
| METHOD FOR PHOTODYNAMIC THERAPY OF LEFT TUMORS OF MICE EHRLICH CARCINOMA WITH CHLORINE SERIES PHOTO-SENSITIZER | 2022 |
|
RU2788766C2 |
| METHOD FOR PROPHYLAXIS OF RADIATION DAMAGE | 2006 |
|
RU2312675C1 |
| COMPLEX FOR ENHANCING IMMUNE RESPONSE | 2019 |
|
RU2779622C2 |
| PEPTIDE-IMMUNOGEN USED IN THERAPEUTIC VACCINE FOR METASTATIC BREAST CANCER TREATMENT | 2015 |
|
RU2624862C2 |
| ENDOGENIC PHARMACEUTICAL COMPOSITION PREPARED ON BASIS OF GOAL-SEEKING ACTIVATION OF HUMORAL MEDIATORS OF BRAIN CORTEX NERVE ENDING | 2003 |
|
RU2244928C2 |
| PEPTIDE-IMMUNOGEN USED IN THERAPEUTIC VACCINE FOR TREATMENT OF METASTATIC BREAST CANCER OF CATS AND DOGS | 2015 |
|
RU2612015C2 |
